Article info
Original Article
TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses
Citation
TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses
Publication history
- Received September 9, 2018
- Revision received November 25, 2018
- Accepted November 29, 2018
- First published January 18, 2019.
Article Versions
- View the most recent version of this article
- You are currently viewing a Previous version of this article (31 March 2021).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.